Risk Assessment in API Manufacturing
Risk Assessment in API Manufacturing A Comprehensive Guide by Swapnroop Drugs and Pharmaceuticals Introduction In the highly regulated pharmaceutical industry, risk assessment is a cornerstone of quality, compliance, and patient safety. Active Pharmaceutical Ingredient (API) manufacturing involves complex chemical and operational processes where even minor deviations can impact product quality, regulatory approval, and supply continuity. A structured risk-based approach ensures that potential hazards are identified, analyzed, and mitigated proactively — enabling manufacturers to maintain consistent quality while optimizing operational efficiency. At Swapnroop Drugs and Pharmaceuticals, risk assessment is embedded across the product lifecycle, from process development to commercial manufacturing, ensuring robust and reliable API supply to global markets. What is Risk Assessment in API Manufacturing? Risk assessment is a systematic process used to identify potential hazar...